Andrew Li Jen Kung MD, PhD

Andrew L. Kung, MD, PhD, has been named the new Chairman of the Department of Pediatrics at Memorial Sloan Kettering Cancer Center (MSK). An accomplished physician, researcher, leader, and mentor, Dr. Kung most recently served as the Chief of the Division of Pediatric Hematology, Oncology, and Stem Cell Transplantation at New York-Presbyterian/Morgan Stanley Children’s Hospital and Columbia University Medical Center (CUMC). Dr. Kung formally assumes his new role as Richard J. O’Reilly, MD, steps down as Chairman after more than 30 years.
Dr. Kung is an internationally recognized physician-scientist with a special interest in identifying new targets and developing new treatments for childhood cancer. His translational oncology research has been powered by diverse experimental approaches including genomics, molecular biology, cell biology, drug development, and experimental therapeutics. As Chairman, Dr. Kung will maintain a clinical practice within the Stem Cell Transplantation Program in addition to leading expansion of the clinical program and heading a program of laboratory-based research.
His laboratories will use whole-genome sequencing and integrative analysis to identify genetically encoded and non-oncogene vulnerabilities in pediatric cancers. He will also continue to search for epigenetic vulnerabilities in a variety of cancer types.